Chengdu Gechun Biopharmaceutical
Natural active ingredients from traditional Chinese medicine with 98% purity, offering custom R&D and extensive compound library
About Chengdu Gechun Biopharmaceutical
Green Purity specializes in the extraction and purification of natural active ingredients derived from over 500 types of traditional Chinese medicinal herbs. The company provides individual packages ranging from 5mg to 20mg, ensuring that all products meet stringent quality standards, including HPLC, MS, and NMR tests, with a minimum purity of 98%. Green Purity serves a diverse clientele, including pharmaceutical companies, research institutions, and nutraceutical firms, operating primarily in the health and wellness market. The business model revolves around the sale of high-purity natural compounds, custom research and development services, and a comprehensive compounds library that aims to offer over 3000 unique compounds. Revenue is generated through direct sales of these compounds, custom R&D projects, and bulk production services.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 18.7/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Nov 2023 | $14M | $55M | Sichuan Innovation Development Investment Management · Yuansheng BioVenture | ↗ |
Growth signals
Latest recorded traffic for Chengdu Gechun Biopharmaceutical is 490 monthly website visits, up 16.7% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Chengdu Gechun Biopharmaceutical in its local ecosystem
The Chengdu Gechun Biopharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- SMSichuan Innovation Development Investment Management
Yuansheng BioVenture
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Chengdu Gechun Biopharmaceutical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Chengdu Gechun Biopharmaceutical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








